Data / Form D filings / NEXEON MEDSYSTEMS INC
NEXEON MEDSYSTEMS INC: Form D filings
NEXEON MEDSYSTEMS INC, a biotechnology company in Dallas, TX, filed 5 Form D notices with the SEC between 2010 and 2017. The latest, on July 20, 2017, reports $1.2 million sold of a $2 million offering to 15 investors.
Find out what NEXEON MEDSYSTEMS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1910 PACIFIC AVENUE, SUITE 20000, Dallas, TX, 75201
- Phone
- (844) 919-9990
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2015
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1416172
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 20, 2017 | Amendment | $2,000,000 | $1,165,000 | $835,000 | 15 | Apr 21, 2017 | sec.gov |
| May 4, 2017 | New notice | $2,500,000 | $135,000 | $2,365,000 | 2 | Apr 26, 2017 | sec.gov |
| Dec 5, 2016 | Amendment | $5,500,000 | $4,278,510 | $1,221,490 | 42 | Feb 17, 2016 | sec.gov |
| Apr 13, 2016 | New notice | $2,500,000 | $1,128,073 | $1,371,927 | 0 | Feb 17, 2016 | sec.gov |
| Apr 29, 2010 | New notice | $18,150,340 | $0 | $18,150,340 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| WILLIAM M ROSELLINI | Executive Officer, Director | |
| CHRISTOPHER R MILLER | Executive Officer | |
| RONALD M CONQUEST | Executive Officer, Director | |
| BRIAN C BLISCHAK | Executive Officer | |
| DANIEL P. POWELL | Executive Officer | |
| KENT J GEORGE | Director | |
| MARK C BATES | Executive Officer, Director | |
| MICHAEL J NEITZEL | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jul 17, 2017 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEXEON MEDSYSTEMS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.